ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2025
Comparison of in-Hospital Complication Rates After Transcatheter Aortic Valve Replacement in Patients With Bicuspid Versus Tricuspid Aortic Valves: A Retrospective Cohort Study.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transcatheter Aortic Valve Replacement for Severe Bicuspid Aortic Valve Stenosis: A Systematic Review and Meta-Analysis.JACC. Advances · 2026Article
- Comparison of in-Hospital Complication Rates After Transcatheter Aortic Valve Replacement in Patients With Bicuspid Versus Tricuspid Aortic Valves: A Retrospective Cohort Study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundTranscatheter aortic valve replacement (TAVR) has become a popular alternative to surgical aortic valve replacement (SAVR) for patients with valvular heart disease (VHD), particularly for those with aortic anomalies.
aimsThe study aimed to compare the risks of post-TAVR complications between patients with bicuspid and tricuspid aortic valves and to identify associated risk factors.
methodsThe association between complications and valve type (bicuspid or tricuspid) was assessed. The study also explored various combinations of factors to understand their impact on complications. Separate analyses were conducted to identify specific risk factors for each complication.
resultsOut of the 1154 eligible patients, 508 had bicuspid aortic valves (BAV) and 646 had tricuspid aortic valves (TAV). The study identified 40 cases of acute kidney injury, 134 instances of new-onset permanent pacemaker implantations, 129 occurrences of paravalvular leak, and 30 device successes. The comprehensive logistic regression revealed no statistically significant association between complications and valve type (ORs: 0.52 (95% CI, 0.23-1.09) for acute kidney injury, 1.29 (95% CI, 0.87-1.92) for permanent pacemaker implantation, 1.29 (95% CI, 0.82-2.02) for paravalvular leak, and 0.54 (95% CI, 0.22-1.23) for device success). Total bilirubin (TBIL), albumin (ALB), age, and New York Heart Association (NYHA) scores, among other factors, were associated with specific post-TAVR complications.
conclusionsThe incidence of acute kidney injury, new permanent pacemaker implantations, paravalvular leaks, and device success did not differ significantly between patients with BAV and TAV following TAVR. Specific risk factors for these complications were identified, highlighting the importance of careful clinical monitoring in post-TAVR management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.